CAFC Vacates PTAB's Finding that Meat Prep Patent Was ObviousThe CAFC ruled that the PTAB's decision is unclear and must adhere to the obviousness theory presented in the case.
Save Your Claims: How to Beat the PTAB's 70% All Claims Invalidation RateUnderstanding the differences between district court and PTAB is crucial for effective patent litigation.
CAFC Affirms PTAB's Obviousness Finding Despite Erroneous Claim ConstructionThe CAFC upheld the PTAB's decision, finding an erroneous claim interpretation that did not affect the outcome of the patent invalidation.
Senate Committee Advances PREVAIL ActThe PREVAIL Act is set to change PTAB procedures, impacting patent challenges and potentially affecting generic drug pricing.New provisions aim to balance patent protection with access to affordable medications.
Legislation is Good, But the PTAB Needs a More Immediate OverhaulIPR provides a faster, cheaper alternative to district court litigation for patent validity assessments.
Patents and the Future of the USPTO in Trump's Second TermPatent reform discussions are heating up in anticipation of President Trump's second term, focusing on specific legislative changes affecting patent eligibility and enforcement.
CAFC Vacates PTAB's Finding that Meat Prep Patent Was ObviousThe CAFC ruled that the PTAB's decision is unclear and must adhere to the obviousness theory presented in the case.
Save Your Claims: How to Beat the PTAB's 70% All Claims Invalidation RateUnderstanding the differences between district court and PTAB is crucial for effective patent litigation.
CAFC Affirms PTAB's Obviousness Finding Despite Erroneous Claim ConstructionThe CAFC upheld the PTAB's decision, finding an erroneous claim interpretation that did not affect the outcome of the patent invalidation.
Senate Committee Advances PREVAIL ActThe PREVAIL Act is set to change PTAB procedures, impacting patent challenges and potentially affecting generic drug pricing.New provisions aim to balance patent protection with access to affordable medications.
Legislation is Good, But the PTAB Needs a More Immediate OverhaulIPR provides a faster, cheaper alternative to district court litigation for patent validity assessments.
Patents and the Future of the USPTO in Trump's Second TermPatent reform discussions are heating up in anticipation of President Trump's second term, focusing on specific legislative changes affecting patent eligibility and enforcement.
Director Review Petitions Charge PTAB Analysis of Plant Utility Claims Threatens Competition for U.S. FarmersThe petitions claim PTAB's heightened patentability standard for plant utility claims undermines competition in seed markets.
False USPTO Narratives and the Urgent Need for PTAB ReformThe Senate's approval of PREVAIL marks a significant step towards PTAB reform amidst ongoing debates and concerns.
Report Indicates PTAB Judges Will Soon Be Required to Return to In-Person WorkPTAB judges' required return to the office may threaten efficiency and timeliness of patent decisions.
USPTO Issues Final Rule on Director Review Process, Scraps After Final Consideration PilotThe USPTO has formalized its interim Director Review process for PTAB decisions following the Supreme Court's Arthrex ruling.
Director Review Petitions Charge PTAB Analysis of Plant Utility Claims Threatens Competition for U.S. FarmersThe petitions claim PTAB's heightened patentability standard for plant utility claims undermines competition in seed markets.
False USPTO Narratives and the Urgent Need for PTAB ReformThe Senate's approval of PREVAIL marks a significant step towards PTAB reform amidst ongoing debates and concerns.
Report Indicates PTAB Judges Will Soon Be Required to Return to In-Person WorkPTAB judges' required return to the office may threaten efficiency and timeliness of patent decisions.
USPTO Issues Final Rule on Director Review Process, Scraps After Final Consideration PilotThe USPTO has formalized its interim Director Review process for PTAB decisions following the Supreme Court's Arthrex ruling.
The PTAB's 70% All-Claims Invalidation Rate Continues to Be a Source of ConcernThe All-Claims Invalidation Rate for patents has escalated dramatically, indicating significant challenges within the U.S. patent system.
Amici Spar Over Proper Bounds of Agency Rulemaking for NHK/Fintiv FrameworkNHK/Fintiv framework is valid but should be scrutinized for its binding authority on PTAB decision-making.
No Concrete Plans, No Standing: Federal Circuit's Latest on IPR AppealsFederal courts can only address actual controversies, not hypothetical situations, as established by the standing doctrine.The Platinum Optics v. Viavi Solutions case reiterates the importance of standing requirements in patent appeals.
The PTAB's 70% All-Claims Invalidation Rate Continues to Be a Source of ConcernThe All-Claims Invalidation Rate for patents has escalated dramatically, indicating significant challenges within the U.S. patent system.
Amici Spar Over Proper Bounds of Agency Rulemaking for NHK/Fintiv FrameworkNHK/Fintiv framework is valid but should be scrutinized for its binding authority on PTAB decision-making.
No Concrete Plans, No Standing: Federal Circuit's Latest on IPR AppealsFederal courts can only address actual controversies, not hypothetical situations, as established by the standing doctrine.The Platinum Optics v. Viavi Solutions case reiterates the importance of standing requirements in patent appeals.
Winning Strategies at the Federal CircuitKnowing the Federal Circuit is crucial for success in patent appeals.
Nautilus or Packard: A Recent PGR Petition Highlights Perils of USPTO Flip-FlopsPost grant challenges at the PTAB involve a mix of prosecution, litigation, and uncertainty.